Normal serum beta-galactosidase in juvenile GM1 gangliosidosis

Pediatr Neurol. 1994 Jun;10(4):317-9. doi: 10.1016/0887-8994(94)90129-5.

Abstract

GM1 gangliosidosis is a genetic disease with lysosomal beta-galactosidase deficiency caused by mutations of the gene coding for this enzyme. However, apparently normal enzyme activity was found in plasma or serum from juvenile GM1 gangliosidosis patients homozygous for a mutation, R201C (201Arg-->Cys), after clotting for 30 min. This extracellular fluid finding is unusual in patients with primary and genetic deficiency of beta-galactosidase. The serum enzyme activity became relatively low only after 3 1/2-hour clotting because its increase in normal controls was not observed in these patients. beta-Galactosidase assay is not always reliable, particularly with serum or plasma as an enzyme source, for the diagnosis of hereditary beta-galactosidase deficiency, unless it is conducted under well-controlled conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Base Sequence
  • Blood Coagulation
  • Child
  • Child, Preschool
  • Female
  • Gangliosidosis, GM1 / enzymology*
  • Gangliosidosis, GM1 / genetics
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mutation
  • beta-Galactosidase / blood*
  • beta-Galactosidase / deficiency
  • beta-Galactosidase / genetics

Substances

  • beta-Galactosidase